Ten‐year survival of breast cancer patients with low expression of ezrin was 76.5% (95% confidence interval (CI) = 0.736–0.794), while survival for those with high expression of ezrin was 64.7% (95% CI = 0.584–0.710). The gene discussed is EZR; the disease is breast carcinoma.